DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR MYRBETRIQ

« Back to Dashboard

Clinical Trials for Myrbetriq

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00410514	A Study of Mirabegron (YM178) in Men With Lower Urinary Tract Symptoms (LUTS) and Bladder Outlet Obstruction (BOO)	Completed	Astellas Pharma Inc	Phase 2	2006-12-01	This study examined the safety, tolerability, and efficacy of mirabegron (YM178) compared to placebo.
NCT00688688	Study to Test the Long Term Safety and Efficacy of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder	Completed	Astellas Pharma Inc	Phase 3	2008-04-01	The study is intended to test the safety, tolerability, efficacy of two doses of long term once daily (qd) treatment of Mirabegron in patients with symptoms of overactive bladder and secondly to compare these with active comparator.
NCT00689104	Study to Test the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder	Completed	Astellas Pharma Inc	Phase 3	2008-04-01	The study is intended to test efficacy, safety and tolerability of two doses of Mirabegron against placebo and compare the efficacy and safety with active comparator in patients with symptoms of overactive bladder.

Clinical Trial Conditions for Myrbetriq

Condition Name

Condition Name for Myrbetriq
Intervention	Trials
Overactive Bladder	12
Urinary Bladder, Overactive	5
Lower Urinary Tract Symptoms	4

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Myrbetriq
Intervention	Trials
Urinary Bladder, Overactive	19
Urologic Diseases	6
Urinary Bladder Diseases	6

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Myrbetriq

Trials by Country

Trials by Country for Myrbetriq
Location	Trials
United States	189
Canada	37
Denmark	9
Germany	9
United Kingdom	8

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Myrbetriq
Location	Trials
New York	9
California	8
Massachusetts	8
Florida	8
Virginia	7

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Myrbetriq

Clinical Trial Phase

Clinical Trial Phase for Myrbetriq
Clinical Trial Phase	Trials
Phase 4	9
Phase 3	10
Phase 2/Phase 3	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Myrbetriq
Clinical Trial Phase	Trials
Completed	14
Recruiting	12
Not yet recruiting	9

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Myrbetriq

Sponsor Name

Sponsor Name for Myrbetriq
Sponsor	Trials
Astellas Pharma Europe B.V.	7
Astellas Pharma Inc	6
Astellas Scientific & Medical Affairs, Inc.	3

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Myrbetriq
Sponsor	Trials
Other	23
Industry	23
NIH	2

Export unavailable in trial.
Subscribe for complete access.